Results 201 to 210 of about 13,750 (216)

Prospective Study of Rituximab in Chemotherapy-Dependent Human Immunodeficiency Virus–Associated Multicentric Castleman's Disease: ANRS 117 CastlemaB Trial

Journal of Clinical Oncology, 2007
Renaud Verdon, Eric Oksenhendler
exaly  

Idiopathic multicentric Castleman's disease: a systematic literature review

Lancet Haematology,the, 2016
Amy Y Liu, Christopher S Nabel, Brian S Finkelman   +2 more
exaly  

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Blood, 2005
Tadamitsu Kishimoto
exaly  

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy

Blood, 2014
David C Fajgenbaum, Frits van Rhee, Christopher S Nabel   +2 more
exaly  

Surgery in Castleman's Disease

Annals of Surgery, 2012
Klaus-Martin Schulte
exaly  

The full spectrum of Castleman disease: 273 patients studied over 20 years

British Journal of Haematology, 2018
Eric Oksenhendler, David Boutboul, David C Fajgenbaum   +2 more
exaly  

The clinical spectrum of Castleman's disease

American Journal of Hematology, 2012
Angela Dispenzieri, Thomas M Habermann
exaly  

Interleukin-6: designing specific therapeutics for a complex cytokine

Nature Reviews Drug Discovery, 2018
Christoph Garbers, Sylvia Heink, Stefan Rose-John   +2 more
exaly  

Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?

American Journal of Hematology, 2019
Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose   +2 more
exaly  

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

Blood, 2018
David C Fajgenbaum
exaly